Search
for
Sort by
Research 181–210 of 1000+
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Mechanisms of autophagy and their implications in dermatological disorders
- Biologics in the management of childhood atopic dermatitis
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- “<i>Nomen Omen</i>: The Myth of God Janus”
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia